Evidence map›Paper›PMID 27295498›Full record

ArticleAging2016

Mitophagy-driven mitochondrial rejuvenation regulates stem cell fate.

Alejandro Vazquez-Martin, Chris Van den Haute, Sílvia Cufí, Bruna Corominas-Faja, Elisabet Cuyàs, Eugeni Lopez-Bonet, Esther Rodriguez-Gallego, Salvador Fernández-Arroyo, Jorge Joven, Veerle Baekelandt and 1 more

Open access · greenAbstract read
In one paragraph

Article in Aging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Coupling of stemness maintenance with cell cycle control in stem cells.Frontiers in cell and developmental biology · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. An Overview: The Diversified Role of Mitochondria in Cancer Metabolism.International journal of biological sciences · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Alejandro Vazquez-MartinCancer Research Group, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Chris Van den HauteLaboratory for Neurobiology and Gene Therapy, Department of Neurosciences, Katholieke Universiteit Leuven, Leuven, Flanders, Belgium.
Sílvia CufíJosep Carreras Leukemia Research Institute, Stem Cell Lab, Barcelona, Spain.
Bruna Corominas-FajaMolecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain.
Elisabet CuyàsMolecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain.
Eugeni Lopez-BonetDepartment of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona, Catalonia, Spain.
Esther Rodriguez-GallegoUnitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitaria Pere Virgili (IISPV), Universitat Rovira i Virgili, Reus, Spain.
Salvador Fernández-ArroyoUnitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitaria Pere Virgili (IISPV), Universitat Rovira i Virgili, Reus, Spain.
Jorge JovenUnitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitaria Pere Virgili (IISPV), Universitat Rovira i Virgili, Reus, Spain.
Veerle BaekelandtLaboratory for Neurobiology and Gene Therapy, Department of Neurosciences, Katholieke Universiteit Leuven, Leuven, Flanders, Belgium.
Javier A MenendezMolecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain.
Institut d'Investigació Biomèdica de Girona · ESInstitut d'Investigació Sanitària Pere Virgili · ESKU Leuven · BEHospital Universitari de Girona Doctor Josep Trueta · ESJosep Carreras Leukaemia Research Institute · ESLatvian Biomedical Research and Study Centre · LVUniversidad Rovira i Virgili · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our understanding on how selective mitochondrial autophagy, or mitophagy, can sustain the archetypal properties of stem cells is incomplete. PTEN-induced putative kinase 1 (PINK1) plays a key role in the maintenance of mitochondrial morphology and function and in the selective degradation of damaged mitochondria by mitophagy. Here, using embryonic fibroblasts fromPINK1 gene-knockout (KO) mice, we evaluated whether mitophagy is a causal mechanism for the control of cell-fate plasticity and maintenance of pluripotency. Loss of PINK1-dependent mitophagy was sufficient to dramatically decrease the speed and efficiency of induced pluripotent stem cell (iPSC) reprogramming. Mitophagy-deficient iPSC colonies, which were characterized by a mixture of mature and immature mitochondria, seemed unstable, with a strong tendency to spontaneously differentiate and form heterogeneous populations of cells. Although mitophagy-deficient iPSC colonies normally expressed pluripotent markers, functional monitoring of cellular bioenergetics revealed an attenuated glycolysis in mitophagy-deficient iPSC cells. Targeted metabolomics showed a notable alteration in numerous glycolysis- and TCA-related metabolites in mitophagy-deficient iPSC cells, including a significant decrease in the intracellular levels of α-ketoglutarate -a key suppressor of the differentiation path in stem cells. Mitophagy-deficient iPSC colonies exhibited a notably reduced teratoma-initiating capacity, but fully retained their pluripotency and multi-germ layer differentiation capacity in vivo. PINK1-dependent mitophagy pathway is an important mitochondrial switch that determines the efficiency and quality of somatic reprogramming. Mitophagy-driven mitochondrial rejuvenation might contribute to the ability of iPSCs to suppress differentiation by directing bioenergetic transition and metabolome remodeling traits. These findings provide new insights into how mitophagy might influence the stem cell decisions to retain pluripotency or differentiate in tissue regeneration and aging, tumor growth, and regenerative medicine.

Indexed as

AnimalsCell LineageCellular ReprogrammingEnergy MetabolismFibroblastsMetabolomicsMiceMice, KnockoutMitochondriaMitophagyProtein KinasesPTEN-Induced Putative KinaseStem CellsProtein KinasesPTEN-Induced Putative Kinasecancerepigeneticsmitochondriamitophagypluripotencystem cells

Identifiers

PMID27295498
PMCPMC4993334
OpenAlexW2436400456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.